Specify a stock or a cryptocurrency in the search bar to get a summary
CogState Ltd
CGSCogstate Limited, a neuroscience technology company, engages in the creation, validation, and commercialization of digital brain health assessments used in both academic and industry sponsored research. Its cognitive services include project management, data management, scientific consulting, statistical analysis, scales procurement, rater training, and monitoring solutions. The company is involved in the design and provision of quality assurance services in clinical trials, focused on the administration, scoring, and recording of conventional brain health assessments. Its technology and associated services are used to quantify the effect of diseases and drugs, and devices or other interventions on human subjects participating in clinical trials primarily conducted by pharmaceutical and biotechnology companies. In addition, the company provides Cognigram, a computerized test to aid healthcare professionals for cognitive decline. Cogstate Limited was incorporated in 1999 and is based in Melbourne, Australia. Address: 367 Collins Street, Melbourne, VIC, Australia, 3000
Analytics
WallStreet Target Price
2.23 AUDP/E ratio
19.3Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures CGS
Dividend Analytics CGS
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History CGS
Stock Valuation CGS
Financials CGS
Results | 2019 | Dynamics |